IWC
ACXP icon

Integrated Wealth Concepts’s Acurx Pharmaceuticals ACXP Stock Holding History

Integrated Wealth Concepts’s Portfolio ACXP Stock Details ACXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.33K Buy
+4,729
New +$9.84K ﹤0.01% 4750

Other funds holding ACXP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PFS
Prospect Financial Services Melville, New York $197M AUM 24.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

Integrated Wealth Concepts's ACXP Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Acurx Pharmaceuticals (ACXP) in Q2 2026: 4,729 shares worth $7.33K. The stake represents ﹤0.01% of the portfolio and ranks #4750 among its holdings.

19 funds tracked by Wall St. Rank hold ACXP as of Q2 2026.

  • Integrated Wealth Concepts held 4,729 shares of Acurx Pharmaceuticals worth $7.33K as of Q2 2026.
  • Acurx Pharmaceuticals was a new Integrated Wealth Concepts position in Q2 2026.
  • Acurx Pharmaceuticals made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #4750 holding.
  • 19 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.